Noven Financial Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,171
Closed -$23K 42
2016
Q3
$23K Buy
1,171
+976
+501% +$19.2K 0.01% 41
2016
Q2
$23K Hold
195
0.02% 38
2016
Q1
$22K Hold
195
0.02% 41
2015
Q4
$37K Buy
195
+71
+57% +$13.5K 0.03% 39
2015
Q3
$21K Buy
+124
New +$21K 0.02% 36